The marijuana fintech's stock price has fallen in recent months amid regulatory uncertainty for cannabis financial services.

The times are tough and there are growing concerns about an economic downturn. The Nasdaq had its worst session since 2022 ...

Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA), a clinical stage biopharmaceutical company that has been developing a treatment ...

Many high-flying stocks have nosedived over the past week, and stock splits are no longer in the spotlight. There have been ...

Still, stock splits generally happen less during downturns ... It has made a stellar recovery from the late 2021-2022 selloffs and has recovered from troughs of around $630 to over $2,073.

Regeneron Pharmaceuticals, Inc. faces Eylea revenue decline but shows growth potential with Dupixent & Libtayo. Click for ...

Constellation Energy Corporation gains momentum with AI-driven growth and a $29.1B Calpine acquisition. Click for more on CEG ...

Moderna CEO Stéphane Bancel received an annual compensation package worth $19.87 million last year, the largest he’s ever ...

The electric vehicle maker's stock is down more than 50% from recent ... After sitting on it since 2022, the social media platform X offloaded nearly $5 billion of the debt that Musk used to ...

Intel on Wednesday (Mar 12) named former board member and chip industry veteran Tan Lip-Bu as its CEO and signalled the ...

Real-time index price for TSX Composite Index (TXCX), along with buy or sell indicators, analysis, charts, historical performance, news and more ...